T.L. Hardy
Impact in
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Emergency Medicine top 10%
- Poisoning and overdose treatments
Papers in
-
- Liver Disease Diagnosis and Treatment 3
- Microscopic Colitis 1
-
- Drug-Induced Hepatotoxicity and Protection 4
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Peter H. Bach (2 shared papers)David M. Brown (1 shared paper)David Houghton (1 shared paper)Linda Errington (1 shared paper)Christopher P. Day (1 shared paper)Christopher J. Stewart (1 shared paper)Leah Avery (1 shared paper)Michael I. Trenell (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (1 paper)Journal of Hepatology (1 paper)The Lancet (1 paper)Diabetologia (1 paper)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
T.L. Hardy
10 papers receiving 194 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 48
- Emergency Medicine 33
- Toxicology 11
- Nephrology 17
- Pharmacology 31
Countries citing papers authored by T.L. Hardy
This map shows the geographic impact of T.L. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.L. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.L. Hardy more than expected).
Fields of papers citing papers by T.L. Hardy
This network shows the impact of papers produced by T.L. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.L. Hardy. The network helps show where T.L. Hardy may publish in the future.
Co-authors
The 25 scholars most cited alongside T.L. Hardy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 75 | |
| 2 | 1968 | 40 | |
| 3 | 1985 | 38 | |
| 4 | 1984 | 21 | |
| 5 | 2021 | 13 | |
| 6 | 2017 | 9 | |
| 7 | 1970 | 4 | |
| 8 | Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ""FIB-C3 Score"" for Detection and Staging of Advanced Non-Alcoholic Fatty Liver Disease in a Large International Multi-Centre Patient Cohort | 2017 | 3 |
| 9 | 1953 | 2 | |
| 10 | 2012 | 1 |
About T.L. Hardy
T.L. Hardy is a scholar working on Epidemiology, Pharmacology, Hepatology, Molecular Biology and Pharmacology, having authored 10 papers that have together received 206 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Liver Diseases and Immunity (2 papers), Liver Disease and Transplantation (2 papers), Microscopic Colitis (1 paper), Poisoning and overdose treatments (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Pharmacology (48 citations), Emergency Medicine (33 citations), Toxicology (11 citations), Nephrology (17 citations) and Pharmacology (31 citations). T.L. Hardy has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Peter H. Bach, David M. Brown, David Houghton, Linda Errington, Christopher P. Day, Christopher J. Stewart, Leah Avery, Michael I. Trenell, Stuart McPherson and Laura J Neilson. Their work appears in journals such as Toxicology and Applied Pharmacology, Journal of Hepatology, The Lancet, Diabetologia and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.